FDA Adverse Event Malfunction Summary report: N

ARCHITECT CYCLOSPORINE

MDR report key: 2588226 · Received May 25, 2012

Report

Report Number
1415939-2012-00218
Event Type
Malfunction
Date Received
May 25, 2012
Report Date
May 2, 2012
Manufacturer
ABBOTT LABORATORIES
Product Code
MKW
PMA / PMN Number
K080751
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). AN INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.

Additional Manufacturer Narrative · 1

ACCURACY TESTING WAS PERFORMED TO ASSESS THE PERFORMANCE OF THE ARCHITECT CYCLOSPORINE ASSAY LOT 11074M500. RESULTS OF THIS TESTING PROTOCOL SHOWED THAT THE ACCEPTANCE CRITERIA WERE MET. CUSTOMER COMPLAINT DATA WAS REVIEWED AND NO ADVERSE TRENDS WERE IDENTIFIED. THE ARCHITECT CYCLOSPORINE PACKAGE INSERT WAS REVIEWED AND WAS FOUND TO ADEQUATELY ADDRESS THE ISSUE OF DISCREPANT RESULTS. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

THE ACCOUNT STATED THAT THEIR ARCHITECT CYCLOSPORINE RESULTS ARE LOWER THAN RESULTS FROM ANOTHER FACILITY ((B)(6)). A PATIENT SAMPLE GENERATED A CYCLOSPORINE RESULT OF 70 NG/ML. THE SAMPLE WAS TESTED AT THE (B)(6) AND A RESULT OF 100 NG/ML WAS GENERATED. THE PATIENT'S PREVIOUS CYCLOSPORINE RESULTS WERE: ON 12/13/2011 75.9 NG/ML, 1/12/2012 120 NG/ML, 3/06/2012 89 NG/ML, 4/24/2012 57.2 NG/ML. THE CYCLOSPORINE RESULTS FROM THE DRESDEN FACILITY WERE: ON 10/10/2011 112 NG/ML, 01/23/2012 105 NG/ML, 04/11/2012 101 NG/ML. THERE WAS NO REPORT OF IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT CYCLOSPORINE MKW ABBOTT LABORATORIES 11074M500

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I2000 ANALYZER: LN 3M74-02| SN (B)(4)| ARCHITECT I2000 ANALYZER: LN 3M74-02| SN (B)(4)